We report here that the expression of the breast luminal differentiation markers estrogen receptor and GATA3 in metastatic ductal breast cancers with a luminal phenotype is not generally lost or decreased upon regional or distant metastasis. This evidence concerns the gene ESR1 and breast carcinoma.